Meta-Analysis Confirms Peptides Extend Lifespan and Improve Healthy Aging in Worms by 46%

A meta-analysis of nine studies found that peptide supplementation reduced mortality by 46% and improved multiple markers of healthy aging in C. elegans worms.

RPEP-084052024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Meta-analysis of 9 studies using Caenorhabditis elegans (nematode worm model organism)
Participants
Meta-analysis of 9 studies using Caenorhabditis elegans (nematode worm model organism)

What This Study Found

Peptide supplementation significantly extended the lifespan of C. elegans, reducing mortality risk by 46% (hazard ratio = 0.54, 95% CI: 0.47-0.62, p<0.05). Beyond living longer, peptide-treated worms also showed signs of healthier aging: pharyngeal pumping rate increased significantly (SMD = 1.64), bending frequency improved (SMD = 1.67), and lipofuscin accumulation — a marker of cellular aging — decreased dramatically (SMD = -4.48).

Subgroup analysis revealed that doses of 0.1-1 mg/mL showed the best anti-aging effects (HR = 0.50, 95% CI: 0.38-0.65), suggesting an optimal dosing range for peptide-based lifespan extension.

Key Numbers

2879 articles screened · 9 studies included · HR=0.54 (46% mortality reduction) · SMD=1.64 pumping rate · SMD=1.67 bending frequency · SMD=-4.48 lipofuscin · Optimal dose 0.1-1 mg/mL

How They Did This

Systematic literature search across PubMed, Scopus, and Web of Science yielded 2,879 articles. After deduplication and quality assessment using the STAIR checklist, nine studies met inclusion criteria. Data were pooled using hazard ratios for survival and standardized mean differences for health markers. Subgroup analysis examined dose-response relationships.

Why This Research Matters

While individual studies have suggested peptides may slow aging, this meta-analysis pools data from nine studies to provide stronger statistical evidence. The finding that peptides not only extend lifespan but also improve markers of healthy aging (movement, feeding, reduced cellular damage) is particularly meaningful — living longer matters most when quality of life is preserved.

The Bigger Picture

Aging research is increasingly focused on interventions that extend not just lifespan but healthspan — the period of healthy, functional living. This meta-analysis strengthens the case that peptides are among the most promising anti-aging compounds, offering benefits across multiple aging markers simultaneously. C. elegans findings have historically predicted some aging interventions that also work in mammals.

What This Study Doesn't Tell Us

C. elegans is a simple nematode worm, so these results may not translate to mammals or humans. The nine included studies used different peptide types, sources, and experimental conditions. The meta-analysis combines heterogeneous peptide interventions, so the optimal specific peptides for anti-aging cannot be identified from these pooled results.

Questions This Raises

  • ?Which specific types of peptides (food-derived, synthetic, or endogenous) drive the strongest anti-aging effects?
  • ?Do these anti-aging benefits translate to mammalian models, and through what molecular pathways?
  • ?Is there a ceiling effect at higher peptide doses, and what explains the optimal 0.1-1 mg/mL range?

Trust & Context

Key Stat:
46% mortality reduction Peptide supplementation reduced the risk of death in C. elegans by nearly half (HR=0.54) while also improving three key markers of healthy aging
Evidence Grade:
This is a meta-analysis pooling data from nine preclinical studies, providing stronger evidence than any individual study. However, all data come from C. elegans worms, not mammals or humans, limiting clinical applicability.
Study Age:
Published in 2024, this is a recent meta-analysis synthesizing the current state of evidence for peptide anti-aging effects in C. elegans.
Original Title:
Anti-aging effect of peptides on Caenorhabditis elegans: a meta-analysis.
Published In:
Journal of the science of food and agriculture, 104(11), 6902-6913 (2024)
Database ID:
RPEP-08405

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Why use worms to study anti-aging effects of peptides?

C. elegans worms are widely used in aging research because they share many fundamental biological pathways with humans, have short lifespans (2-3 weeks) allowing rapid study of lifespan effects, and are genetically well-characterized. Many interventions that extend worm lifespan have later shown similar effects in mammals.

What types of peptides were tested in these studies?

The meta-analysis pooled results from various peptide types used across nine studies. While the specific peptides varied (including food-derived and bioactive peptides), the overall finding was that peptide supplementation as a class significantly extended lifespan and improved healthy aging markers.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-08405·https://rethinkpeptides.com/research/RPEP-08405

APA

Huang, Chao; Zhu, Ling; Zhang, Hui; Liu, Tongtong; Wang, Li; Wu, Gangcheng. (2024). Anti-aging effect of peptides on Caenorhabditis elegans: a meta-analysis.. Journal of the science of food and agriculture, 104(11), 6902-6913. https://doi.org/10.1002/jsfa.13522

MLA

Huang, Chao, et al. "Anti-aging effect of peptides on Caenorhabditis elegans: a meta-analysis.." Journal of the science of food and agriculture, 2024. https://doi.org/10.1002/jsfa.13522

RethinkPeptides

RethinkPeptides Research Database. "Anti-aging effect of peptides on Caenorhabditis elegans: a m..." RPEP-08405. Retrieved from https://rethinkpeptides.com/research/huang-2024-antiaging-effect-of-peptides

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.